Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Nogueras González GM"'
Autor:
Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Brooks N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Matulay J; Department of Urology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Li R; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA., Nogueras González GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grossman HB; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
BJU international [BJU Int] 2021 Nov; Vol. 128 (5), pp. 634-641. Date of Electronic Publication: 2021 May 05.
Autor:
Chin JL; Department of Urology, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada., Lavi A; Department of Urology, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada., Metcalfe MJ; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Siddiqui K; Department of Urology, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada., Dewar M; Department of Urology, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada., Petros FG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li R; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nogueras González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nair SM; Department of Urology, University of Western Ontario, London Health Sciences Centre, London, Ontario, Canada., Ward JF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pisters L; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
The Journal of urology [J Urol] 2021 Sep; Vol. 206 (3), pp. 646-654. Date of Electronic Publication: 2021 Apr 18.
Autor:
Shapiro DD; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Gregg JR; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Lim AH; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Nogueras-González GM; Department of Biostatistics, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Choi H; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Kang HC; Department of Abdominal Imaging, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Inguillo IA; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Chapin BF; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Davis JW; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA., Ward JF; Department of Urology, Anderson Cancer Centre, University of Texas, M.D., Houston, TX, USA.
Publikováno v:
BJU international [BJU Int] 2021 Mar; Vol. 127 (3), pp. 340-348. Date of Electronic Publication: 2020 Jun 29.
Autor:
Chi WJ; Department of Hospital Dentistry, Walter Reed National Military Medical Center, Bethesda, MD, USA. amoschi@gmail.com., Myers JN; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aponte-Wesson RA; Section of Oral Oncology and Maxillofacial Prosthodontics, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Otun AO; Section of Oral Oncology and Maxillofacial Prosthodontics, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nogueras-González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Geng Y; Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chambers MS; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mchamber@mdanderson.org.; Section of Oral Oncology and Maxillofacial Prosthodontics, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mchamber@mdanderson.org.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Dec; Vol. 28 (12), pp. 1-12. Date of Electronic Publication: 2020 Nov 24.
Autor:
Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Estrov Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nogueras-González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Skinner J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Poku R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DellaSala S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Luthra R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., O'Brien S; Chao Family Comprehensive Cancer Center, University of California, Irvine, California., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer [Cancer] 2020 Apr 01; Vol. 126 (7), pp. 1502-1511. Date of Electronic Publication: 2020 Jan 30.
Autor:
Mizrak Kaya D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nogueras González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer, Houston, Texas, USA., Harada K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Blum Murphy MA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee JH; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bhutani MS; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weston B; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Thomas I; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rogers JE; Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Das P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Badgwell BD; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, jajani@mdanderson.org.
Publikováno v:
Oncology [Oncology] 2020; Vol. 98 (8), pp. 542-548. Date of Electronic Publication: 2020 May 20.
Autor:
Yalniz F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Abou Dalle I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel K; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Loghavi S; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nogueras González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cortes J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
American journal of hematology [Am J Hematol] 2019 Sep; Vol. 94 (9), pp. 984-991. Date of Electronic Publication: 2019 Jun 24.
Autor:
Li R; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Metcalfe MJ; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tabayoyong WB; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nogueras González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Grossman HB; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinney CP; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: akamat@mdanderson.org.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2019 May; Vol. 2 (3), pp. 286-293. Date of Electronic Publication: 2018 Sep 10.
Autor:
Jain P; Department of Leukemia.; Division of Cancer Medicine, and., Kantarjian H; Department of Leukemia., Boddu PC; Department of Leukemia., Nogueras-González GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; and., Verstovsek S; Department of Leukemia., Garcia-Manero G; Department of Leukemia., Borthakur G; Department of Leukemia., Sasaki K; Department of Leukemia., Kadia TM; Department of Leukemia., Sam P; Department of Leukemia., Ahaneku H; Department of Leukemia., O'Brien S; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA., Estrov Z; Department of Leukemia., Ravandi F; Department of Leukemia., Jabbour E; Department of Leukemia., Cortes JE; Department of Leukemia.
Publikováno v:
Blood advances [Blood Adv] 2019 Mar 26; Vol. 3 (6), pp. 851-861.
Autor:
Ohanian M; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Rozovski U; b Department of Hematology , Davidoff Cancer Center at Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv , Israel., Kanagal-Shamanna R; c Department of Hematopathology , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Abruzzo LV; d Department of Pathology , Ohio State University , Columbus , OH , USA., Loghavi S; c Department of Hematopathology , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Kadia T; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Futreal A; e Department of Genomic Medicine , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Bhalla K; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Zuo Z; c Department of Hematopathology , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Huh YO; c Department of Hematopathology , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Post SM; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Ruvolo P; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Garcia-Manero G; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Andreeff M; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Kornblau S; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Borthakur G; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Hu P; f School of Health Professions , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Medeiros LJ; c Department of Hematopathology , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Takahashi K; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Hornbaker MJ; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Zhang J; e Department of Genomic Medicine , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Nogueras-González GM; g Department of Biostatistics , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Huang X; g Department of Biostatistics , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Verstovsek S; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Estrov Z; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Pierce S; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Ravandi F; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Kantarjian HM; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Bueso-Ramos CE; c Department of Hematopathology , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA., Cortes JE; a Department of Leukemia , The University of Texas at MD Anderson Cancer Center , Houston , TX , USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Jan; Vol. 60 (1), pp. 37-48. Date of Electronic Publication: 2018 May 09.